Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02037997
What this trial is testing

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Fudan University 80
Early research (Phase 1)Study completedNCT01851096
What this trial is testing

Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma

Who this might be right for
Cancer
Esanex Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02753764
What this trial is testing

Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma

Who this might be right for
Corticosteroid Resistant (CR) Asthmatics
National Jewish Health 2
Testing effectiveness (Phase 2)UnknownNCT02771314
What this trial is testing

Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 48
Large-scale testing (Phase 3)Looking for participantsNCT06441006
What this trial is testing

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco 400
Post-approval studies (Phase 4)Study completedNCT00878878
What this trial is testing

Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).

Who this might be right for
Pulmonary Hypertension
GE Healthcare 30
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableStudy completedNCT01945398
What this trial is testing

IMT in Ventilatory Muscle Metaboreflex in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Federal University of Rio Grande do Sul 13
Testing effectiveness (Phase 2)Study completedNCT01982955
What this trial is testing

Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)

Who this might be right for
Non-small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 88
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Not applicableStudy completedNCT04706299
What this trial is testing

Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing

Who this might be right for
Prevention of COVID-19
The Cleveland Clinic 20
Not applicableEnded earlyNCT04436120
What this trial is testing

Treatment Resistance Following Anti-cancer Therapies

Who this might be right for
Disease Progression
Pfizer 38
Very early researchNot Yet RecruitingNCT07338123
What this trial is testing

Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli

Who this might be right for
Pneumonia
Chinese PLA General Hospital 240
Post-approval studies (Phase 4)Study completedNCT01136239
What this trial is testing

The Effect of High Dose N-acetylcysteine on Airtrapping and Airway Resistance in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
COPD
Kwong Wah Hospital 133
Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Study completedNCT02489903
What this trial is testing

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Who this might be right for
Small Cell CarcinomaCarcinoma, Non-Small-Cell LungNeuroendocrine Tumors+1 more
EpicentRx, Inc. 139
Not applicableStudy completedNCT00671151
What this trial is testing

Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

Who this might be right for
COPD
Hospital Universitari Son Dureta 35
Testing effectiveness (Phase 2)Study completedNCT05128929
What this trial is testing

Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).

Who this might be right for
Pulmonary Hypertension
Stanford University 17
Early research (Phase 1)Study completedNCT04176328
What this trial is testing

Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Neupharma Srl 12
Next Page